PCN64 - Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain
Autor: | González Flores, E, Vera García, R, Sabater Cabrera, E, Tirado Mercier, E, Granell Villalon, M |
---|---|
Zdroj: | In Value in Health November 2016 19(7):A719-A720 |
Databáze: | ScienceDirect |
Externí odkaz: |